ACES
03 Nov 2020
Trial Summary
This study will evaluate the feasibility and safety of adjuvant chemotherapy in patients with oesophageal cancer who received neoadjuvant chemotherapy and undergone curative surgery.
Acronym:
ACES
ACTRN/NCT /ethics:
ACTRN12616000554460
Scientific title:
Feasibility study of adjuvant chemotherapy in patients with oesophageal cancer who received neoadjuvant chemotherapy and underwent curative surgery
Sponsor / Cooperative group:
Flinders Medical Centre
Trial & Patient Characteristics
| Cancer Type | Stomach & Oesophageal |
|---|---|
| Trial Type | Treatment |
| Phase | Phase I |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | Stomach & Oesophageal |
| Cancer Stage | Early/In Situ, Locally Recurrent or Locally Advanced |
| Anticipated Start Date | 2016-04-29 |
| Anticipated End Date | - |
Participating Hospitals
| Hospital | Flinders Medical Centre |
|---|---|
| Clinical Trial Coordinator | Alex Scott-Hoy |
| alex.scott-hoy@sa.gov.au | |
| Phone | 08 8204 4830 |
| Principal Investigator | Dr Amitesh Roy |
| Recruitment Status | Recruiting |
| Hospital | Royal Adelaide Hospital |
|---|---|
| Clinical Trial Coordinator | Anne Milton |
| anne.milton@sa.gov.au | |
| Phone | 08 7074 2342 |
| Principal Investigator | Dr Nimit Singhal |
| Recruitment Status | Recruiting |